Gene · 1066
Papers3,256
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 3,256
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Enteroviral epitope mimicry enables NK cell-mediated targeting of ASPH in hepatocellular carcinoma. | bioRxiv | 2026 | 41993253 | PubTator, text mining | PubMed |
| Molnupiravir is not a selective CES2 probe substrate: in vitro evidence for CES1 involvement. | Drug Metab Dispos | 2026 | 41967311 | PubTator, text mining | PubMed |
| Thromboxane A2 synthase is an off target of the CES1 small-molecule inhibitor WWL113. | Prostaglandins Other Lipid Mediat | 2026 | 41935416 | PubTator, text mining | PubMed |
| Drug-drug interactions induced by immunosuppressants through inhibition of human carboxylesterases. | Drug Metab Dispos | 2026 | 41903396 | PubTator, text mining | PubMed |
| Pharmacometabolomics Detects Unreported Clopidogrel Metabolites in the Urine of Kidney and Liver Transplant Recipients. | Metabolites | 2026 | 41893359 | PubTator, text mining | PubMed |
| Integrative analysis of adenosine-related RNA modifications defines molecular subtypes of bladder cancer and identifies CES1 as a driver of tumor progression and immunotherapy resistance. | BMC Cancer | 2026 | 41882633 | PubTator, text mining | PubMed |
| Role of liver X receptors in the pathogenesis and treatment of chronic liver disease (Review). | Mol Med Rep | 2026 | 41860051 | PubTator, text mining | PubMed |
| Unraveling the Link Between Azathioprine and Acute Pancreatitis: Integrating Network Toxicology, Machine Learning, and Mendelian Randomization. | CPT Pharmacometrics Syst Pharmacol | 2026 | 41832938 | PubTator, text mining | PubMed |
| Review of clinical advances in the procedural sedation application of remimazolam. | Front Pharmacol | 2026 | 41808875 | PubTator, text mining | PubMed |
| Characterization of fatty acid amide hydrolase 2 as a drug-metabolizing enzyme: Contribution to the hydrolysis of DS-8500a and its analogs. | Drug Metab Dispos | 2026 | 41806499 | PubTator, text mining | PubMed |
| Insights into antibiotic resistance gene dynamics during Tanfloc-induced flocculation-storage process for cyanobacteria removal in an algae-laden drinking water source. | J Environ Manage | 2026 | 41797140 | PubTator, text mining | PubMed |
| Genetic Evidence Reveals Causal Effect of Circulating Proteome on Random Glucose: A Mendelian Randomization Study. | J Diabetes Res | 2026 | 41789253 | PubTator, text mining | PubMed |
| Tailoring low-dose aspirin to prevent preeclampsia: translational and biomarker insights. | Front Med (Lausanne) | 2026 | 41788727 | PubTator, text mining | PubMed |
| Genomic analysis of dental pulp mesenchymal stromal cells for therapeutic applications. | Regen Ther | 2026 | 41777871 | PubTator, text mining | PubMed |
| Re: Comments on "Association of Clopidogrel Genetic Polymorphism With Efficacy and Safety for Ischemic Stroke or Transient Ischemic Attack: A Systematic Review and Updated Meta-Analysis". | J Clin Neurol | 2026 | 41775387 | PubTator, text mining | PubMed |
| Remdesivir in COVID-19: pros and cons. | Front Pharmacol | 2026 | 41769697 | PubTator, text mining | PubMed |
| An Overview of Anticoagulant Drugs Pharmacology, Therapeutic Approaches, Limitations and Perspectives. | Pharmaceutics | 2026 | 41754906 | PubTator, text mining | PubMed |
| The Remediation Mechanism of Soil Atrazine Contamination by Vermicompost: A Metagenomic Perspective. | Microorganisms | 2026 | 41753703 | PubTator, text mining | PubMed |
| Quality of Life Outcomes After Endoscopic Cholesteatoma Surgery: A Prospective Cohort Study. | J Clin Med | 2026 | 41753244 | PubTator, text mining | PubMed |
| Raman Spectroscopic Signatures of Hepatic Carcinoma: Progress and Future Prospect. | Int J Mol Sci | 2026 | 41752159 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1066/papers?page=3